Success Metrics

Clinical Success Rate
82.4%

Based on 28 completed trials

Completion Rate
82%(28/34)
Active Trials
24(31%)
Results Posted
32%(9 trials)
Terminated
6(8%)

Phase Distribution

Ph phase_4
1
1%
Ph not_applicable
12
15%
Ph early_phase_1
1
1%
Ph phase_1
9
12%
Ph phase_2
4
5%

Phase Distribution

10

Early Stage

4

Mid Stage

1

Late Stage

Phase Distribution27 total trials
Early Phase 1First-in-human
1(3.7%)
Phase 1Safety & dosage
9(33.3%)
Phase 2Efficacy & side effects
4(14.8%)
Phase 4Post-market surveillance
1(3.7%)
N/ANon-phased studies
12(44.4%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

71.8%

28 of 39 finished

Non-Completion Rate

28.2%

11 ended early

Currently Active

24

trials recruiting

Total Trials

78

all time

Status Distribution
Active(29)
Completed(28)
Terminated(11)
Other(10)

Detailed Status

Completed28
Recruiting19
unknown10
Terminated6
Active, not recruiting5
Withdrawn5

Development Timeline

Analytics

Development Status

Total Trials
78
Active
24
Success Rate
82.4%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (3.7%)
Phase 19 (33.3%)
Phase 24 (14.8%)
Phase 41 (3.7%)
N/A12 (44.4%)

Trials by Status

recruiting1924%
active_not_recruiting56%
completed2836%
withdrawn56%
not_yet_recruiting56%
unknown1013%
terminated68%

Recent Activity

Clinical Trials (78)

Showing 20 of 78 trialsScroll for more
NCT03952637Phase 1

A Phase 1/2 Study of Intravenous Gene Transfer With an AAV9 Vector Expressing Human Beta-galactosidase in Type I and Type II GM1 Gangliosidosis

Recruiting
NCT07132788

Understanding the Effects of Pulmonary Arterial Hypertension on Lean Muscle Mass

Recruiting
NCT02911142Phase 1

Lenalidomide Combined With Modified DA-EPOCH and Rituximab (EPOCH-R2) in Primary Effusion Lymphoma or KSHV-associated Large Cell Lymphoma

Active Not Recruiting
NCT06409585

Cardiomyopathies and Heart Muscle Diseases: Cardiac Imaging in the Evaluation of Myocardial Fibrosis Transition

Recruiting
NCT00923013Phase 2

Cladribine With Simultaneous or Delayed Rituximab to Treat Hairy Cell Leukemia

Active Not Recruiting
NCT02769962Phase 1

Trial of EP0057, a Nanoparticle Camptothecin With Olaparib in People With Relapsed/Refractory Small Cell Lung Cancer

Terminated
NCT05201014

Cancer Survivor Cardiomyopathy Detection

Terminated
NCT05920824

Atrial Functional Mitral Regurgitation and Tricuspid Regurgitation

Recruiting
NCT07483203

A Study Of Clinical Implications Of Pulmonary Vascular Disease In Valvular Heart Disease

Recruiting
NCT05699200Not Applicable

A Study to Analyze the Role of Sympathetic Nervous System in Spontaneous Coronary Artery Dissection

Recruiting
NCT07630402Not Applicable

Optimization of Cardiac Imaging in Women With Early-Stage Breast Cancer

Recruiting
NCT06023576Phase 2

A Study of Blood Pressure Control During Cancer Treatment

Recruiting
NCT06652763

Manganese-enhanced Magnetic Resonance Imaging (MEMRI) in Heart Failure With Preserved Ejection Fraction

Recruiting
NCT04458883Not Applicable

The Next Leap in Cardiac Magnetic Resonance Imaging:Cycling the Field

Recruiting
NCT02780128Phase 1

Next Generation Personalized Neuroblastoma Therapy

Terminated
NCT04002531Not Applicable

A One Visit Follow Up of Adults With Fabry Disease Who Started Long-term Enzyme Replacement Therapy As Children

Completed
NCT04827563

Dyspnea and Cardiotoxicity in Multiple Myeloma Patients Who Receive Carfilzomib

Terminated
NCT07438301

Septic Shock Hemodynamic Respond to Volume Resuscitation Versus Vasopressor Administration

Not Yet Recruiting
NCT05208567

London Valvular Heart Disease and Reduced Ejection Fraction Detection in a Multi-ethnic Community Using Cardiac Ultrasound

Recruiting
NCT05164744

Cardiac Magnetic Resonance Tissue Characterization in COVID-19 Survivors

Recruiting

Drug Details

Intervention Type
DIAGNOSTIC TEST
Total Trials
78